MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

SJ-172550

CAS No. : 431979-47-4

MCE 站：SJ-172550

产品活性：SJ-172550是MDMX的小分子抑制剂; 与野生型p53肽竞争性结合于MDMX的EC₅₀值为5 μM。

研究领域：Apoptosis  |  Metabolic Enzyme/Protease

作用靶点：MDM-2/p53  |  E1/E2/E3 Enzyme

In Vitro: The p53 pathway is disrupted in virtually every human tumor. SJ-172550 binds the p53-binding pocket of MDMX, thereby displacing p53. SJ-172550 binds reversibly to MDMX and effectively kills retinoblastoma cells in which the expression of MDMX is amplified. The effect of SJ-172550 is additive when combined with an MDM2 inhibitor nutlin-3a. SJ-172550 acts through a complicated mechanism in which the compound forms a covalent but reversible complex with MDMX and locks MDMX into a conformation that is unable to bind p53. The relative stability of this complex is influenced by many factors including the reducing potential of the media, the presence of aggregates.

相关产品：Bioactive Compound Library Plus  |  Apoptosis Compound Library  |  Metabolism/Protease Compound Library  |  Anti-Cancer Compound Library  |  Autophagy Compound Library  |  Anti-Aging Compound Library  |  Oxygen Sensing Compound Library  |  Ubiquitination Compound Library  |  Ferroptosis Compound Library  |  Pyroptosis Compound Library  |  Glutamine Metabolism Compound Library  |  Anti-Pancreatic Cancer Compound Library  |  Anti-Blood Cancer Compound Library  |  Nutlin-3a  |  Pifithrin-α hydrobromide  |  Eprenetapopt  |  PYR-41  |  BI8622  |  Ginkgolic Acid  |  SZL P1-41  |  2-D08  |  Amifostine  |  Pifithrin-μ  |  RITA  |  Indole-3-carbinol  |  NSC232003  |  BI8626  |  PRT4165  |  MI-773  |  Pifithrin-α, p-Nitro, Cyclic  |  DKM 2-93  |  NSC319726  |  Amifostine thiol dihydrochloride  |  PYZD-4409  |  PK11007  |  SMIP004  |  Solasodine  |  Inauhzin  |  TZ9  |  GS143

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。